EF
WVE icon

Entrust Financial’s Wave Life Sciences WVE Stock Holding History

Entrust Financial’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436 Sell
75
-450
-86% -$2.98K ﹤0.01% 440
2026
Q1 		$3.81K Buy
525
+180
+52% +$2.35K ﹤0.01% 377
2025
Q4 		$5.87K Buy
+345
New +$3.51K ﹤0.01% 336

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Entrust Financial's WVE Position: Q2 2026 in Review

Entrust Financial reduced its Wave Life Sciences (WVE) stake by 86% in Q2 2026, selling an estimated $2.98K and leaving 75 shares worth $436. The position accounts for ﹤0.01% of the portfolio, ranked #440.

Entrust Financial first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.87K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Entrust Financial held 75 shares of Wave Life Sciences worth $436 as of Q2 2026.
  • Entrust Financial sold 450 Wave Life Sciences shares in Q2 2026, an estimated $2.98K.
  • Wave Life Sciences made up ﹤0.01% of Entrust Financial's portfolio in Q2 2026, its #440 holding.
  • Entrust Financial first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Entrust Financial's Wave Life Sciences position peaked at $5.87K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.